Indication for a role of regulatory T cells for the advent of influenza A (H1N1)-related pneumonia

Clinical and Experimental Immunology

Volumn 161, Issue 3, 2010, Pages 576-583

  Raftogiannis, M ^a,b   Antonopoulou, A ^a   Baziaka, F ^a   Spyridaki, A ^a   Koutoukas, P ^a   Tsaganos, T ^a   Savva, A ^a   Pistiki, A ^a   Georgitsi, M ^a   Giamarellos Bourboulis, E J ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Cytokines; H1N1 influenza; Pneumonia; Regulatory T cells

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 6; PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BACTERIAL PNEUMONIA; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME IMMUNOASSAY; FEMALE; FLOW CYTOMETRY; FLU LIKE SYNDROME; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOPHENOTYPING; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; STREPTOCOCCUS PNEUMONIAE; T LYMPHOCYTE SUBPOPULATION; THORAX RADIOGRAPHY; VIRAL RESPIRATORY TRACT INFECTION; VIRUS PNEUMONIA;

ADULT; AGED; ANTIGENS, CD14; FEMALE; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; IMMUNOPHENOTYPING; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTERLEUKIN-6; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PNEUMONIA, BACTERIAL; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 77955767790     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04208.x     Document Type: Article

References (27)

1. Patel M, Dennis A, Flutter C, Khan Z. Pandemic (H1N1) 2009 influenza. Br J Anaesth 2010 104 : 128 142.
2. Tang JW, Shetty N, Lam TT. Features of the new pandemic influenza A/H1N1/2009 virus: virology, epidemiology, clinical and public health aspects. Curr Opin Pulm Med 2010 16 : 235 241.
3. Funk DJ, Siddiqui F, Wiebe K et al. Practical lessons from the first outbreaks: clinical presentation, obstacles, and management strategies for severe pandemic (pH1N1) influenza pneumonitis. Crit Care Med 2010 38 (Suppl. 4 e30 7.
4. World Health Organization: global alert and response. Available at: http://www.who.int/csr/don/2010-01-08/en/index.html (accessed 14 May 2010).
5. Giamarellos-Bourboulis EJ, Raftogiannis M, Antonopoulou A et al. Effect of the novel influenza A (H1N1) virus in the human immune system. PLoS ONE 2009 4 : e8393.
6. Majlessi L, Lo-Man R, Leclerc C. Regulatory B and T cells in infections. Microbes Infect 2008 10 : 1030 1035.
7. Giamarellos-Bourboulis EJ, Zakynthinos S, Baziaka F et al. Soluble triggering receptor expressed on myeloid cells-1 as an antiinflammatory mediator in sepsis. Intensive Care Med 2006 32 : 237 243.
8. Jain S, Kamimoto L, Bramley AM et al. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 2009 361 : 1935 1944.
9. Petric M, Comanor L, Petti CA. Role of the laboratory in diagnosis of influenza during seasonal epidemics and potential pandemics. J Infect Dis 2006 194 (Suppl. 2 S98 110.
10. Perez-Padilla R, de la Rosa-Zamboni S, de Leon SP et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009 361 : 680 689.
11. Chowell G, Bertozzi SM, Colchero MA et al. Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 2009 361 : 674 679.
12. Kumar A, Zarychanski R, Pinto R et al. Critically ill patients with 2009 influenza A (H1N1) infection in Canada. JAMA 2009 302 : 1872 1879.
13. Dominguez-Chérit G, Lapinsky SE, Macias AE et al. Critically ill patients with 2009 influenza A (H1N1) in Mexico. JAMA 2009 302 : 1880 1887.
14. Gibot S, Cravoisy A, Kolopp-Sarda MN, Béné MC, Faure G, Bollaert PE. Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis. Crit Care Med 2005 33 : 792 796.
15. Giamarellos-Bourboulis EJ, Tsaganos T, Spyridaki E et al. Early changes of CD4-positive lymphocytes and NK cells in patients with severe Gram-negative sepsis. Crit Care 2006 10 : R166.
16. Müller B, Schuetz P, Trampuz A. Circulating biomarkers as surrogates for bloodstream infections. Int J Antimicrob Agents 2007 30 (Suppl. 1 S16 23.
17. Rittisch D, Flierl MA, Ward PA. Harmful molecular mechanisms in sepsis. Nat Immunol 2008 8 : 776 786.
18. Gogos CA, Drosou E, Bassaris HP, Skoutelis A. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 2000 181 : 176 180.
19. Tschoeke SK, Moldawer LL. Human leukocyte expression in sepsis: what have we learned? Crit Care Med 2005 33 : 236 237.
20. Lee N, Wong CK, Chan PKS et al. Hypercytokinemia and hyperactivation of phosphoro-p38 mitogen-activated protein kinase in severe human influenza A virus infection. Clin Infect Dis 2007 45 : 723 731.
21. To JKW, Hung IFN, Li IWS et al. Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis 2010 50 : 850 859.
22. Tuvim MJ, Evans SE, Clement CG, Dickey BF, Gilbert BE. Augmented lung inflammation protects against influenza A pneumonia. PLoS ONE 2009 4 : e4176.
23. Tessarz AS, Cerwenka A. The TREM/DAP12 pathway. Immunol Let 2008 116 : 111 116.
24. Jones AE, Fiechtl JF, Brown MD, Ballew JJ, Kline JA. Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med 2007 50 : 34 41.
25. Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med 2008 36 : 941 952.
26. Tang BMP, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007 7 : 210 217.
27. Giamarellos-Bourboulis EJ, Mega A, Grecka P et al. Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient? Intensive Care Med 2002 28 : 1351 1356.